Home/Filings/4/0000905148-24-002946
4//SEC Filing

Kennedy Lawrence T. Jr 4

Accession 0000905148-24-002946

CIK 0001439725other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 3:15 PM ET

Size

7.9 KB

Accession

0000905148-24-002946

Insider Transaction Report

Form 4
Period: 2024-11-05
Kennedy Lawrence T. Jr
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2024-11-05$1.36/sh+51,200$69,88810,356,024 total(indirect: By Trust)
  • Purchase

    Common Stock

    2024-11-06$1.36/sh+20,000$27,18010,376,024 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By LLC)
    2,775,386
  • Common Stock

    (indirect: By Trust)
    12,267,873
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3564 to $1.3599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

BIODESIX INC

CIK 0001439725

Entity typeother

Related Parties

1
  • filerCIK 0001830773

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 3:15 PM ET
Size
7.9 KB